Proton Pump Inhibitors May Affect Responses to Atezolizumab in Patients with Urothelial Cancer
PHILADELPHIA – Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with...
PHILADELPHIA – Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with...
PHILADELPHIA – Among premenopausal women with breast cancer, those who were previously treated with radiation for a primary childhood,...
PHILADELPHIA – Adult survivors of childhood abdominal and pelvic cancers who had been treated with radiation therapy experienced abnormalities...
Submission deadline is Friday, December 4, 2020 PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting...
SAN ANTONIO – Mary-Claire King, PhD, FAACR, will receive the William L. McGuire Memorial Lecture Award at the 2020...
PHILADELPHIA – Periodontal disease was associated with an increased risk of two precursors of colorectal cancer, according to results...
PHILADELPHIA – Cancer Discovery, a journal of the American Association for Cancer Research, will publish a COVID-19 and Cancer...
PHILADELPHIA – Hispanic adults reported significant diversity in their trust of health information sources, suggesting that information tailored to...
PHILADELPHIA – Lipophilic statins, a type of medication commonly prescribed to lower blood cholesterol, were associated with reduced mortality...
Young cancer patients may benefit from germline genetic testing PHILADELPHIA – Young patients ages 18–39 with early-onset cancer were...